Clinical and research
Innovation focused on improving patient outcomes
Our teams push boundaries and expand medical knowledge:
Research and development
Working in partnership with leading universities, our innovative Research and Development (R&D) programme is improving safety and treatments for patients and donors, including the support of national research dedicated to understanding and treating COVID-19.
Clinical Trials Unit
Our UKCRC-registered Clinical Trials Unit supports studies across all our products and services, including research in response to COVID-19. The Unit works with leading researchers to design, conduct, analyse, and publish clinical trials and other prospective studies.
Organ donation and transplantation resources
Get the latest organ-specific statistics, reports, guidance materials including guidance specific to COVID-19, procedural documents, strategic initiatives, meeting presentations and agendas from advisory and patient support groups.
Component Development Laboratory
We are part of NHS Blood and Transplant’s internationally recognised Research and Development programme. We specialise in translational research that changes the way blood is processed, stored or tested.
About our work assessing the risks and improving the prevention of transfusion transmissible diseases.
Working across NHSBT and Public health England, the unit monitors infections in blood, tissue and organ donors, and in transfusion recipients. The unit collates and analyses data from the four UK blood services to produce surveillance reports and inform/evaluate policy changes relating to infection risk.
Operational support is provided by our governance and clinical effectiveness, and statistical teams.
These support the development of organ allocation schemes, data analysis and statistics, and ensure compliance with:
Care Quality Commission standards